Cognivue proudly presented recent data evaluating cognition in patients with Multiple Sclerosis during the Miami Neuro Symposium in November. This presentation comes as a result of a scientifically productive partnership between Cognivue and Dr. Roberto Bomprezzi and team from the University of Massachusetts Memorial Center, Department of Neurology (Worcester, MA).
The presentation had a lot of interest as neurologists understand the impact that cognitive impairment has on overall productivity and quality of life in patients with MS at all ages. The data confirms that Cognivue is a reliable, easy-to-use, computerized testing method to assess cognitive impairment in patients with MS.
Pictured are Kerime Ararat, MD from UMass Memorial, and Cognivue Chief Medical Officer Reina Benabou, MD, PhD.